R Dirk Allison Sells 2,364 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) CEO R Dirk Allison sold 2,364 shares of the business’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $249,071.04. Following the transaction, the chief executive officer directly owned 183,150 shares of the company’s stock, valued at $19,296,684. The trade was a 1.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

R Dirk Allison also recently made the following trade(s):

• On Tuesday, February 24th, R Dirk Allison sold 4,988 shares of Addus HomeCare stock. The stock was sold at an average price of $106.98, for a total transaction of $533,616.24.

Addus HomeCare Price Performance

Shares of ADUS opened at $103.53 on Friday. The firm has a fifty day simple moving average of $109.22 and a two-hundred day simple moving average of $112.95. The firm has a market cap of $1.92 billion, a PE ratio of 19.87, a P/E/G ratio of 1.44 and a beta of 0.91. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ADUS shares. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Barclays dropped their price objective on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a report on Tuesday. Stephens decreased their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. BMO Capital Markets began coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target on the stock. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Hedge Funds Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC boosted its position in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC lifted its stake in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare in the 4th quarter worth $29,000. Private Trust Co. NA boosted its holdings in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the period. Finally, Arax Advisory Partners increased its stake in Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.